Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in patients on kidney replacement therapy: observational study using the OpenSAFELY-UKRR and SRR databases

BACKGROUND: Due to limited inclusion of patients on kidney replacement therapy (KRT) in clinical trials, the effectiveness of coronavirus disease 2019 (COVID-19) therapies in this population remains unclear. We sought to address this by comparing the effectiveness of sotrovimab against molnupiravir,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Bang, Campbell, Jacqueline, Carr, Edward J, Tazare, John, Nab, Linda, Mahalingasivam, Viyaasan, Mehrkar, Amir, Santhakumaran, Shalini, Steenkamp, Retha, Loud, Fiona, Lyon, Susan, Scanlon, Miranda, Hulme, William J, Green, Amelia C A, Curtis, Helen J, Fisher, Louis, Parker, Edward, Goldacre, Ben, Douglas, Ian, Evans, Stephen, MacKenna, Brian, Bell, Samira, Tomlinson, Laurie A, Nitsch, Dorothea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616487/
https://www.ncbi.nlm.nih.gov/pubmed/37915915
http://dx.doi.org/10.1093/ckj/sfad184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616487/
https://www.ncbi.nlm.nih.gov/pubmed/37915915
http://dx.doi.org/10.1093/ckj/sfad184

Ejemplares similares